Showing 1 - 4 results of 4 for search 'Yu. A. Kostina', query time: 0.02s Refine Results
  1. 1
    Microbial agents as triggers of developing multiple sclerosis

    Microbial agents as triggers of developing multiple sclerosis by A. V. Lapshtaeva, Yu. G. Abrosimova, T. Ya. Eremkina, Yu. A. Kostina

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Changes in vascular endothelial growth factor level in <i>Helicobacter pylori</i>-associated gastroduodenal diseases

    Changes in vascular endothelial growth factor level in <i>Helicobacter pylori</i>-associated gastroduodenal diseases by L. V. Matveeva, R. H. Kapkaeva, A. N. Chudaikin, A. A. Soldatova, L. M. Mosina, Yu. A. Kostina, G. A. Solodovnikova

    Published 2021-12-01
    Get full text
    Article
  3. 3
    STUDY OF CLINICAL AND PATHOGENETIC EFFECTS OF ANTI-VIRAL DRUG BASED ON FAVIPIRAVIR IN COMORBID PATIENTS WITH COVID-19 AT THE OUTPATIENT STAGE OF TREATMENT

    STUDY OF CLINICAL AND PATHOGENETIC EFFECTS OF ANTI-VIRAL DRUG BASED ON FAVIPIRAVIR IN COMORBID PATIENTS WITH COVID-19 AT THE OUTPATIENT STAGE OF TREATMENT by L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, Yu. A. Kostina, M. S. Iskandyarova, E. V. Negodnova, V. V. Eremeev, L. F. Sabirov, E. V. Semeleva

    Published 2021-12-01
    Get full text
    Article
  4. 4
    STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

    STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD by O. A. Radaeva, L. A. Balykova, K. Ya. Zaslavskaya, A. V. Taganov, P. A. Bely, Yu. A. Kostina, E. V. Negodnova, S. V. Mashnina, D. D. Bessheinov, M. S. Iskandyarova, V. V. Eremeev, N. M. Chumakov

    Published 2022-05-01
    Get full text
    Article

Search Tools: